Journal List > Korean J Obstet Gynecol > v.54(5) > 1088274

Lee, Yoon, Chung, and Park: The serum vitamin D nutritional status and its relationship with skeletal status in Korean postmenopausal women

Abstract

Objective

The purpose of this study was to evaluate the nutritional status of vitamin D and its relationship with skeletal status in postmenopausal Korean women.

Methods

We studied 322 ambulatory postmenopausal women recruited in Seoul, Korea. The research was performed from October 2008 to March 2009. Serum 25-hydroxyvitamin D (25[OH]D) concentration was measured by radioimmunoassay and serum parathyroid hormone (PTH) level was measured by immunoradiometric assay. The bone mineral densities were measured at the lumbar spine and femur using dual energy x-ray absorptiometry.

Results

The mean serum 25(OH)D level was 16.0 ± 7.1 ng/mL and the mean serum PTH level was 34.0 ± 13.7 pg/mL. About 90% of all studied postmenopausal women were in vitamin D inadequate status. Although serum vitamin D level was the lowest in osteoporotic postmenopausal women, no significant differences were found in serum level of vitamin D among normal, osteopenic, and osteoporotic women (P =0.4689). Vitamin D level in elderly women over 65 years was significant lower than non-elderly women (P =0.0011). But no significant differences were found in vitamin D levels between early and late postmenopausal women (P =0.9882). Serum vitamin D level in winter and spring was significantly lower than serum vitamin D level in autumn (P < 0.0001). Serum vitamin D level was negatively correlated with serum PTH level (r = -0.3054, P < 0.0001).

Conclusion

About three quarters of postmenopausal women were in vitamin D deficient status regardless of the status of bone health. Therefore, it is recommended to prescribe the supplemental vitamin D to improve bone health of postmenopausal Korean women.

Figures and Tables

Fig. 1
Vitamin D nutritional status according to bone health (P=0.4689).
kjog-54-241-g001
Fig. 2
Correlation between serum 25-hydroxyvitamin D (25OHD) and parathyroid hormone (PTH) (P<0.0001).
kjog-54-241-g002
Table 1
Clinical characteristics of total 322 postmenopausal subjects
kjog-54-241-i001

25(OH)D, 25-hydroxy vitamin D; PTH, parathyroid hormone; BMI, body mass index; SD, standard deviation.

Table 2
Vitamin D nutritional status
kjog-54-241-i002

25(OH)D, 25-hydroxy vitamin D.

Table 3
Vitamin D level and relationship with bone health
kjog-54-241-i003

SD, standard deviation; Min, minimum; Max, maximum.

P=0.0569.

Table 4
Vitamin D level according to age, menopause duration and seasonal variation
kjog-54-241-i004

SD, standard deviation; Min, minimum; Max, maximum.

References

1. Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982. 36:1014–1031.
2. Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med. 1997. 103:20S–25S.
3. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992. 13:719–764.
4. Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 1995. 53:599–602.
5. Park HM, Kim JG, Choi WH, Lim SK, Kim GS. The vitamin D nutritional status of postmenopausal women in Korea. Korean J Bone Metab. 2003. 10:47–55.
6. Kim H, Ku SY, Kim SH, Choi YC, Moon SY, Kim JG. A study of vitamin D insufficiency in postmenopausal Korean women. J Korean Soc Osteoporos. 2003. 1:12–21.
7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007. 357:266–281.
8. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000. 72:690–693.
9. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004. 164:2335–2342.
10. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998. 351:805–806.
11. Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology. 1996. 137:2187–2190.
12. Harris SS, Soteriades E, Coolidge JA, Mudgal S, Dawson-Hughes B. Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population. J Clin Endocrinol Metab. 2000. 85:4125–4130.
13. Lim YW, Sun DH, Kim YS. Osteoporosis: pathogenesis and fracture prevention. J Korean Hip Soc. 2009. 21:6–16.
TOOLS
Similar articles